Since adult hippocampal neurogenesis is impaired during aging and neurodegenerative diseases such as Alzheimer’s diseases, targeting Prdm16 could be a novel approach to enhance plasticity in the diseased brain. This evidence concerns the gene PRDM16 and early-onset autosomal dominant Alzheimer disease.